Globus Medical (NYSE: GMED) released fourth-quarter and full year 2025 results that exceeded Wall Street’s forecast, citing successful integration of NuVasive and Nervo and strong domestic spine sales growth. The musculoskeletal technology company reported a 25.7% increase in year-on-year Q4 sales, to $826.4 million, beating market expectations of $803.3 million. Non-GAAP diluted Q4 earnings per […]
Nuvasive
FDA clears orthopedics robot for TKA from Globus Medical
Globus Medical has won FDA clearance for its ExcelsiusFlex robotic ortho surgery navigations system in knee procedures — and an expanded indication for its ExcelsiusHub system. Audubon, Pennsylvania-based Globus Medical received the 510(k) clearance on June 14 for the robotic positioning system, which was designed to help surgeons position implant components and prepare bony anatomy […]
Globus Medical lays off 157 at former NuVasive headquarters
Globus Medical (NYSE:GMED) is letting go of 157 workers at NuVasive’s former headquarters campus in San Diego, according to a WARN report filed with the state of California. The notice, dated Jan. 3 and shared by the California Employment Development Department with MassDevice, says the campus will stay open. Workers received notice of the layoffs on […]
Globus Medical, NuVasive complete merger
Globus Medical and Nuvasive today announced the completion of their previously announced merger. The news sent GMED shares down more than 1% to $53.30 apiece by midday today, while MassDevice‘s MedTech 100 Index was up slightly. Truist analysts cited investor fears over the deal causing near-term business disruptions. Globus Medical officials plan to discuss the […]
The 10 largest orthopedic device companies in the world
Two of the world’s largest orthopedic device companies expect accelerated revenue growth this year. Stryker and Zimmer Biomet both upped their 2023 guidance during recent earnings calls, a sign that orthopedic procedures are bouncing back from the COVID-19 pandemic. GlobalData predicted earlier this year that the recovery will lift the ortho devices market to nearly $50 […]
Globus Medical beats The Street in Q2 as it prepares for spine tech merger
Globus Medical (NYSE: GMED) reported second-quarter results that beat analyst expectations, upping its full-year sales guidance as it prepares to merge with NuVasive. The news yesterday evening came a day after NuVasive reported mixed results heading into the merger, which would create the world’s second-largest spine tech company after Medtronic. The CEOs of both Globus Medical […]
NuVasive reports mixed Q2 results ahead of expected merger with Globus Medical
NuVasive officials still plan to close the spine tech company’s merger with Globus Medical in the present quarter, despite the FTC scrutiny. Along with reporting mixed second-quarter results, NuVasive CEO Chris Barry yesterday evening stuck by plans to merge with Globus Medical in the third quarter and create what would be the second-largest spine tech […]
NuVasive, Globus Medical shareholders approve merger
NuVasive (Nasdaq:NUVA) and Globus Medical (NYSE:GMED) both saw shareholders approve their proposed merger yesterday. In February, the companies announced an agreement to combine in an all-stock transaction. The deal values NuVasive at $3.1 billion, with Globus shareholders owning roughly three-fourths of the newly merged company. BTIG analysts raised the question of potential anti-trust challenges for the deal. […]
NuVasive expands indications of limb lengthening system to include pediatrics
NuVasive this week announced it received FDA 510(k) clearance for the use of its Precice all-internal limb lengthening solution for pediatric patients. Precice is a magnetically adjustable technology that uses an external remote to non-invasively lengthen implants. The system’s nail has been implanted more than 15,000 times by more than 2,000 surgeons. “Precice has over […]
NuVasive misses overall estimates on Wall Street
Nuvasive (Nasdaq:NUVA) this week posted fourth-quarter results that missed overall estimates on Wall Street. The San Diego-based orthopedic company reported profits of $24.1 million, or 42¢ per share, on sales of $305.5 million, for the three months ended Dec. 31, 2022, on sales growth of 1.12% compared to Q4 2021. It also had a profit […]
FDA clears expanded use for NuVasive C360 portfolio
NuVasive (Nasdaq:NUVA) announced today that it received FDA 510(k) clearance for use of its Modulus Cervical interbody implant with a bone void filler. The expanded indication creates new offerings in the cervical segment to surgeons and hospitals. It also further enhances the company’s C360 portfolio, according to a news release. “We believe that delivering differentiated […]
